Anika Therapeutics's total assets for Q1 2026 were $179.39M, a decrease of -5.72% from the previous quarter. ANIK total liabilities were $45.49M for the fiscal quarter, a -2.82% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.